Ligand-mediated decrease of thyroid hormone receptor-α1 in cardiomyocytes by proteosome-dependent degradation and altered mRNA stability

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 2 57-2, 2005, Pages

  Kenessey, Agnes ^a   Ojamaa, Kaie ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b North Shore LIJ Research Institute ^*  (United States)

Author keywords

Adenovirus; C erbA; Neonatal rat ventricular myocyte; Tri iodo L thyronine

Indexed keywords

DACTINOMYCIN; LIOTHYRONINE; MESSENGER RNA; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR BETA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BOLUS INJECTION; CELL CULTURE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HALF LIFE TIME; HEART CONTRACTION; HEART MUSCLE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOVIRIDAE; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; GENE EXPRESSION; LIGANDS; MYOCYTES, CARDIAC; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; RNA STABILITY; RNA, MESSENGER; THYROID HORMONE RECEPTORS ALPHA; TRANSCRIPTION, GENETIC; TRIIODOTHYRONINE;

EID: 12344267572     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00804.2004     Document Type: Article

References (44)

1. Balkman C, Ojamaa K, and Klein I. Time course of the in vivo effects of thyroid hormone on cardiac gene expression. Endocrinology 130: 2001-2006, 1992.
2. Biondi B, Fazio S, Palmieri EA, Carella C, Panza N, Cittadini A, Bone F, Lombardi G, and Sacca L. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 84: 2064-2067, 1999.
3. Brent GA. The molecular basis of thyroid hormone action. N Engl J Med 33: 847-854, 1994.
4. Bunn CF, Neidig JA, Freidinger KE, Stankiewicz TA, Weaver BS, McGrew J, and Allison LA. Nucleocytoplasmic shuttling of the thyroid hormone receptor α. Mol Endocrinol 15: 512-533, 2001.
5. Cuadrado A, Navarro-Yubero C, Furneaux H, and Munoz A. Neuronal HuD gene encoding a mRNA stability regulator is transcriptionally repressed by thyroid hormone. J Neurochem 86: 763-773, 2003.
6. Dace A, Zhao L, Park KS, Furuno T, Takamura N, Nakanishi M, West BL, Hanover JA, and Cheng SY. Hormone binding induces rapid proteosome-mediated degradation of thyroid hormone receptors. Proc Natl Acad Sci USA 97: 8985-8990, 2000.
7. D'Amati G, Di Gioia CRT, Mentuccia D, Pistilli D, Proietti-Pannunzi L, Miraldi F, Gallo P, and Celi FS. Increased expression of thyroid hormone receptor isoforms in end-stage human congestive heart failure. J Clin Endocrinol Metab 86: 2080-2084, 2001.
8. Dillmann WH. Cellular action of thyroid hormone on the heart. Thyroid 12: 447-452, 2002.
9. Gloss B, Trost SU, Bluhm WF, Swanson EA, Clark R, Winkfein R, Janzen KM, Giles W, Chassande O, Samarut J, and Dillmann WH. Cardiac ion channel expression and contractile function in mice with deletion of thyroid hormone receptor α or β. Endocrinology 142: 544-550, 2001.
10. Haddad F, Qin AX, McCue SA, and Baldwin KM. Thyroid receptor plasticity in striated muscle types: effects of altered thyroid state. Am J Physiol Endocrinol Metab 274: E1018-E1026, 1998.
11. Hauser S, Adelmant G, Sarraf P, Wright HM, Mueller E, and Spiegelman BM. Degradation of the peroxisome proliferator-activated receptor γ is linked to ligand-dependent activation. J Biol Chem 275: 18527-18533, 2000.
12. Hodin RA, Lazar MA, and Chin WW. Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone. J Clin Invest 85: 101-105, 1990.
13. Kellerman S, Moore JA, Zierhut W, Zimmer HG, Campbell J, and Gerdes AM. Nuclear DNA content and nucleation patterns in rat cardiac myocytes from different models of cardiac hypertrophy. J Mol Cell Cardiol 24: 497-505, 1992.
14. Kinugawa K, Minobe WA, Wood WM, Ridgway EC, Baxter JD, Ribeiro RCJ, Tawadrous MF, Lowes BA, Long CS, and Bristow MR. Signaling pathways responsible for fetal gene induction in the failing human heart. Evidence for altered thyroid hormone receptor gene expression. Circulation 103: 1089-1094, 2001.
15. Kinugawa K, Yonekua K, Ribeiro RCJ, Eto Y, Aoyagi T, Baxter JD, Camacho SA, Bristow MR, Long CS, and Simpson PC. Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy. Circ Res 89: 591-598, 2001.
16. 2+ transport and myocardial relaxation. Circ Res 75: 245-251, 1994.
17. Klein I and Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 344: 501-509, 2001.
18. Ladenson PW, Sherman SI, Baughman KL, Ray PE, and Feldman AM. Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. Proc Natl Acad Sci USA 89: 5251-5255, 1992.
19. Le Bouter S, Demolombe S, Chambellan A, Bellocq C, Aimond F, Toumaniantz G, Lande G, Siavoshian S, Baro I, Pond AL, Nerbonne JM, Leger JJ, Escande D, and Charpentier F. Microarray analysis reveals complex remodeling of cardiac ion channel expression with altered thyroid status. Circ Res 92: 234-242, 2003.
20. Leedman PJ, Stein AR, and Chin WW. Regulated specific protein binding to a conserved region of the 3′ untranslated region of thyrotropin β-subunit mRNA. Mol Endocrinol 9: 375-387, 1995.
21. Liew CC, Jackowski G, Ma T, and Sole MJ. Nonenzymatic separation of myocardial cell nuclei from whole heart tissue. Am J Physiol Cell Physiol 244: C3-C10, 1983.
22. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF, Badesch DB, Groves BM, Gilbert EM, and Bristow MR. Changes in gene expression in the intact human heart. Downregulation of α-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 100: 2315-2324, 1997.
23. Mahaffey KW, Raia TE, Pennock G, Morkin E, and Goldman S. Left ventricular performance and remodeling in rabbits after myocardial infraction. Circulation 91: 794-802, 1995.
24. Mai W, Janier MF, Allioli N, Quignodon L, Chuzel T, Flamant F, and Samarut J. Thyroid hormone receptor a is a molecular switch of cardiac function between fetal and postnatal life. Proc Natl Acad Sci USA 101: 10332-10337, 2004.
25. Maruvada P, Baumann CT, Hager GL, and Yen PM. Dynamic shuttling and intranuclear mobility of nuclear hormone receptors. J Biol Chem 278: 12425-12432, 2003.
26. Moruzzi P, Doria E, and Agostoni PG. Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy. Am J Med 101: 461-467, 1996.
27. Nawaz Z, Lonard DM, Dennis AP, Smith CL, and O'Malley BW. Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci USA 96: 1858-1862, 1999.
28. Ojamaa K, Ascheim D, Hryniewicz K, and Klein I. Thyroid hormone therapy of cardiovascular disease. Cardio Vasc Rev Reports 23: 20-26, 2002.
29. Ojamaa K, Klemperer JD, MacGilvray SS, Klein I, and Samarel A. Thyroid hormone and hemodynamic regulation of β-myosin heavy chain promoter in the heart. Endocrinology 137: 802-808, 1996.
30. Osburn DL, Shao G, Seidel M, and Schulman IG. Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions. Mol Cell Biol 21: 4909-4918, 2001.
31. i and contractile activity. Am J Physiol Cell Physiol 273: C394-C403, 1997.
32. Raaka BM and Samuels HH. Regulation of thyroid hormone nuclear receptor levels in GH1 cells by 3,5,3′-triiodo-L-thyronine. J Biol Chem 256: 6883-6889, 1981.
33. Schmid G and Pfitzer P. Mitoses and binucleated cells in perinatal human hearts. Virchows Arch 48: 59-67, 1985.
34. Staton JM and Leedman PJ. Posttranscriptional regulation of thyrotropin β-subunit messenger ribonucleic acid by thyroid hormone in murine thyrotrope tumor cells: a conserved mechanism across species. Endocrinology 139: 1093-1100, 1998.
35. Suzuki S, Miyamoto T, Opsahl A, Sakurai A, and DeGroot LJ. Two thyroid hormone response elements are present in the promoter of human thyroid hormone receptor β1. Mol Endocrinol 8: 305-314, 1994.
36. Sylven C, Jansson E, Sotonyi P, Waagstein F, Barkhem T, and Bronnegard M. Cardiac nuclear hormone receptor mRNA in heart failure in man. Life Sci 59: 1917-1922, 1996.
37. Tan FL, Moravec CS, Li J, Apperson-Hansen C, McCarthy PM, Young JB, and Bond M. The gene expression fingerprint of human heart failure. Proc Natl Acad Sci USA 99: 11387-11392, 2002.
38. Wikstrom L, Johansson C, Salto C, Barlow C, Barros AC, Baas F, Forrest D, Thoren P, and Vennstrom B. Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha-1. EMBO J 17: 455-461, 1998.
39. Wu Y, Xu B, and Koenig RJ. Thyroid hormone response element sequence and the recruitment of retinoid X receptors for thyroid hormone responsiveness. J Biol Chem 276: 3929-3936, 2001.
40. Xiao Q, Kenessey A, and Ojamaa K. Role of USF1 phosphorylation on cardiac α-myosin heavy chain promoter activity. Am J Physiol Heart Circ Physiol 283: H213-H219, 2002.
41. Xiao Q and Ojamaa K. Regulation of cardiac α-myosin heavy chain gene transcription by a contractile-responsive E-box binding protein. J Mol Cell Cardiol 30: 87-95, 1998.
42. Xu B and Koenig RJ. An RNA binding domain in the thyroid hormone receptor enhances transcriptional activation. J Biol Chem 279: 33051-33056, 2004.
43. Yue P, Long CS, Austin R, Chang KC, Simpson PC, and Massie BM. Post-infarction heart failure in the rat is associated with distinct alterations in cardiac myocyte molecular phenotype. J Mol Cell Cardiol 30: 1615-1630, 1998.
44. Zhang J and Lazar MA. The mechanism of action of thyroid hormones. Annu Rev Physiol 62: 439-466, 2000.